Theratechnologies (NASDAQ:THTX) Releases Earnings Results, Beats Estimates By $0.03 EPS

Theratechnologies (NASDAQ:THTX) released its quarterly earnings data on Thursday. The company reported $0.06 earnings per share for the quarter, topping the consensus estimate of $0.03 by $0.03, Yahoo Finance reports. The firm had revenue of $22.60 million for the quarter. During the same quarter in the previous year, the company earned ($0.03) EPS. Theratechnologies updated its FY 2024 guidance to EPS.

Theratechnologies Stock Down 0.8 %

Shares of NASDAQ THTX opened at $1.26 on Friday. The business’s 50 day moving average price is $1.27 and its two-hundred day moving average price is $1.34. The company has a market cap of $57.70 million, a PE ratio of -6.61 and a beta of 1.41. Theratechnologies has a twelve month low of $0.88 and a twelve month high of $2.58.

Theratechnologies Company Profile

Theratechnologies Inc, a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen.